title: In vivo imaging of CT26 mouse tumours by using cmHsp70.1 monoclonal antibody.
abstract: The major stress-inducible heat shock protein 70 (Hsp70) is frequently present on the cell surface of human tumours, but not on normal cells. Herein, the binding characteristics of the cmHsp70.1 mouse monoclonal antibody (mAb) were evaluated in vitro and in a syngeneic tumour mouse model. More than 50% of the CT26 mouse colon carcinoma cells express Hsp70 on their cell surface at 4°C. After a temperature shift to 37°C, the cmHsp70.1-fluorescein isothiocyanate mAb translocates into early endosomes and lysosomes. Intraoperative and near-infrared fluorescence imaging revealed an enrichment of Cy5.5-conjugated mAb cmHsp70.1, but not an identically labelled IgG1 isotype-matched control, in i.p. and s.c. located CT26 tumours, as soon as 30 min. after i.v. injection into the tail vein. Due to the rapid turnover rate of membrane-bound Hsp70, the fluorescence-labelled cmHsp70.1 mAb became endocytosed and accumulated in the tumour, reaching a maximum after 24 hrs and remained detectable at least up to 96 hrs after a single i.v. injection. The tumour-selective internalization of mAb cmHsp70.1 at the physiological temperature of 37°C might enable a targeted uptake of toxins or radionuclides into Hsp70 membrane-positive tumours. The anti-tumoral activity of the cmHsp70.1 mAb is further supported by its capacity to mediate antibody-dependent cytotoxicity.
authors.affiliation: Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, and Clinical Cooperation Group (CCG) 'Innate Immunity in Tumor Biology', Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Munich, Germany.
authors.forename: Stefan
authors.initials: S
authors.lastname: Stangl
authors.forename: Mathias
authors.initials: M
authors.lastname: Gehrmann
authors.forename: Ralf
authors.initials: R
authors.lastname: Dressel
authors.forename: Frauke
authors.initials: F
authors.lastname: Alves
authors.forename: Christian
authors.initials: C
authors.lastname: Dullin
authors.forename: George
authors.initials: G
authors.lastname: Themelis
authors.forename: Vasilis
authors.initials: V
authors.lastname: Ntziachristos
authors.forename: Eva
authors.initials: E
authors.lastname: Staeblein
authors.forename: Axel
authors.initials: A
authors.lastname: Walch
authors.forename: Isabel
authors.initials: I
authors.lastname: Winkelmann
authors.forename: Gabriele
authors.initials: G
authors.lastname: Multhoff
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000378:metabolism*; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000378:metabolism; D049109:Cell Proliferation; D003952:Diagnostic Imaging / Q000379:methods*; D005260:Female; D005434:Flow Cytometry; D005453:Fluorescence; D018840:HSP70 Heat-Shock Proteins / Q000276:immunology*; D006801:Humans; D007430:Intraoperative Care; D007700:Kinetics; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000473:pathology* / Q000601:surgery; D010537:Peritoneum / Q000473:pathology; D011485:Protein Binding; D040521:Subcutaneous Tissue / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D018840:HSP70 Heat-Shock Proteins
references.citation: J Immunol. 1995 May 1;154(9):4685-92
references.pmid: 7722321
references.citation: Cell Stress Chaperones. 2001 Oct;6(4):337-44
references.pmid: 11795470
references.citation: Mol Imaging. 2009 Jan-Feb;8(1):2-14
references.pmid: 19344571
references.citation: Neoplasia. 2008 Jul;10(7):663-73
references.pmid: 18592006
references.citation: PLoS One. 2008 Apr 02;3(4):e1925
references.pmid: 18382692
references.citation: Cell Stress Chaperones. 2009 Jan;14(1):105-11
references.pmid: 18663603
references.citation: J Immunother. 2006 Jul-Aug;29(4):351-64
references.pmid: 16799330
references.citation: Int J Cancer. 1992 Jun 19;51(4):613-9
references.pmid: 1601523
references.citation: Cell Stress Chaperones. 2000 Nov;5(5):438-42
references.pmid: 11189449
references.citation: Nat Rev Mol Cell Biol. 2009 Aug;10(8):513-25
references.pmid: 19603039
references.citation: Int J Cancer. 1995 Apr 10;61(2):272-9
references.pmid: 7705958
references.citation: Cancer. 2007 Aug 15;110(4):926-35
references.pmid: 17580361
references.citation: Cancer Res. 2005 Jun 15;65(12):5238-47
references.pmid: 15958569
references.citation: Cell Stress Chaperones. 1998 Mar;3(1):6-11
references.pmid: 9585177
references.citation: J Immunol. 1979 Feb;122(2):549-54
references.pmid: 310843
references.citation: Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):820-6
references.pmid: 14529789
references.citation: Cell Death Differ. 2005 Jan;12(1):38-51
references.pmid: 15592361
references.citation: Melanoma Res. 2003 Apr;13(2):147-52
references.pmid: 12690297
references.citation: Proteomics. 2009 May;9(10):2820-35
references.pmid: 19415654
references.citation: J Biol Chem. 2003 Feb 28;278(9):7607-16
references.pmid: 12493773
references.citation: Mol Cancer Ther. 2008 Aug;7(8):2498-508
references.pmid: 18687997
references.citation: J Biol Chem. 2003 Jun 13;278(24):21601-6
references.pmid: 12682040
references.citation: Nat Biotechnol. 2005 Sep;23(9):1147-57
references.pmid: 16151408
references.citation: FASEB J. 2009 Aug;23(8):2467-77
references.pmid: 19289606
references.citation: FASEB J. 2004 Nov;18(14):1636-45
references.pmid: 15522909
references.citation: Immunol Invest. 2007;36(3):233-46
references.pmid: 17558707
references.citation: J Immunol. 2008 Mar 15;180(6):4299-307
references.pmid: 18322243
references.citation: Cell Stress Chaperones. 2008 Spring;13(1):1-10
references.pmid: 18347936
references.citation: N Engl J Med. 2006 Feb 9;354(6):567-78
references.pmid: 16467544